2024 Drrx stock forecast - Based on analysts offering 12 month price targets for DRRX in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .

 
Complete Durect Corp. stock information by Barron's. View real-time DRRX stock price and news, along with industry-best analysis.. Drrx stock forecast

Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottomStock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ... Durect Stock Prediction. MAC. 70Find the latest DURECT Corporation (DRRX) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and investors.Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-BrainerStock Price Forecast. The 8 analysts offering 12-month price forecasts for EyePoint Pharmaceuticals Inc have a median target of 28.00, with a high estimate of 55.00 and a low estimate of 20.00 ...Get the latest DURECT Corp (DRRX) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372. For DURECT stock forecast for 2028 (5 year), 12 predictions are offered for each month of 2028 with average DURECT stock forecast of $0.99, a high forecast of $1.6, and a low …See DURECT Corporation (DRRX) stock analyst estimates, including earnings and revenue, EPS, upgrades and downgrades. Institutional Ownership and Shareholders. Durect Corp (US:DRRX) has 4 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 404,520 shares. Largest shareholders include Jefferies Group LLC, Montchanin Asset Management, Llc, and Regis …It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow …Summary. DRRX is a forever laggard company. In 2021, I noted its strong phase 2a data. There's phase 2b data this year, but the market is completely ignoring this stock.for development and commercialization in other countries. ****CYTR (T/$10) scleroderma etal... DRRX (T/$3) Durect Corp... ... But don't expect its stock price to ...Get the latest Pieris Pharmaceuticals Inc (PIRS) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Durect DRRX is set to give its latest quarterly ... New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).Read today's DRRX news from trusted media outlets at MarketBeat. Skip to main content. S&P 500 4,514.02. DOW 34,947.28. QQQ 386.04. S&P 500's Whirlwind: Big gains, warning whispers & tactical moves. Trading Experts Call It “The Perfect Tesla Trade” (Ad) ... Durect Shares Slide Premarket on Planned Stock Sale >DRRX marketwatch.com ...A. While ratings are subjective and will change, the latest Durect ( DRRX) rating was a downgraded with a price target of $37.00 to $0.00. The current price Durect ( DRRX) is trading at is $0.62 ...Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...Throughout the U.S., the weather can be quite unpredictable, even with state-of-the-art radar, sensors and computer modeling technology right at meteorologists’ fingertips. The Old Farmer’s Almanac first provided valuable statistics and dat...If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI. BigBear.ai. $4.05. APPH. AppHarvest. $0.95. DRRX. Durect.Discover historical prices for DRRX stock on Yahoo Finance. View daily, weekly or monthly format back to when DURECT Corporation stock was issued.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...Nov 6, 2023 · The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ... Alzamend Neuro® is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease, Bipolar disorder, Major Depressive Disorder (“MDD”) and Post-Traumatic Stress Disorder (“PTSD”). Our mission is to rapidly develop and market safe and effective treatments to bring aid to the 43 ...The latest Durect stock prices, stock quotes, news, and DRRX history to help you invest and trade smarter. ... Vanguard Total Stock Market ETF: 2.48: Armistice Capital LLC: 2.21: Vanguard Russell ...See the latest Durect Corp stock price (DRRX:XNAS), related news, valuation, dividends and more to help you make your investing decisions.DRRX Stock Predictions. DRRX Stock Buy or Sell? - Get a free DRRX stock trend analysis report to help you analyze and make a better DRRX stock predictions. The stock analysis service is provided by MarketClub, using their Smart Scan and Trade Triangle technology. It uses technical analysis and the current market condition to give you the best ...ASRT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.08 -- higher than only 2.12% of US-listed equities with positive expected earnings growth. The price/operating cash flow metric for ASSERTIO HOLDINGS INC is higher than just 4.73% of stocks in our set with a positive cash flow.DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ...Mar-09-21 09:00AM. DURECT Corporation Announces Publication of DUR-928's Mechanism of Action. (PR Newswire) DURECT Corp. focuses on advancing novel and potentially lifesaving investigational therapies derived from its Epigenetic Regulator Program. Its pipeline is called DUR-928, an endogenous sulfated oxysterol and an epigenetic …The above table shows the analyst DRRX forecast and predictions for the stock price in 12 month’s time. Date Share Price Average 1Y Price Target Dispersion High Low 1Y Actual price Analysts; Current: US$0.62 Oct 15, 2020 · The Durect stock forecast is 1.3653368157524 USD for 2024 November 26, Tuesday; and 6.830 USD for 2028 November 26, Sunday with technical analysis. Durect (DRRX) stock price prediction is 1.3653368157524 USD. DRRX Stock Forecast - Is DRRX a buy or sell? Find out now with a free analysis on DURECT. Should I buy or sell DRRX? DRRX Stock Analysis - [Full Report] DRRX Chart by TradingView. Accessories Stocks Animal Stocks Biopharma Stocks Biopharmaceutical Stocks Clinic Stocks Clinical StocksLet’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are priced that low for a reason – and the reasons may vary – a low price in itself doesn’t mean that the stock’s fundamentals are sour. Smart investors […]DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.In today’s fast-paced business environment, accurate forecasting is crucial for making informed decisions and staying ahead of the competition. One powerful tool that can help you achieve this is a forecasting Excel template.May 11, 2023 · Analyst Price Forecast Suggests 611.06% Upside. As of ... The put/call ratio of DRRX is 2.39, ... Vanguard Total Stock Market Index Fund Investor Shares holds 6,635K shares representing 27.10% ... Interested in getting the full scoop on DRRX, including earnings and dividends, stock forecast, buy or sell analysis and key stats? If so, you came to the right place. In this DRRX stock guide , we'll address key questions about DRRX, above and beyond what you can find on Yahoo Finance, Zacks, MarketWatch or Morningstar.What this means: InvestorsObserver gives Durect Corp (DRRX) an overall rank of 37, which is below average. Durect Corp is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. A rank of 37 means that 63% of stocks appear more favorable to our system.Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.Find the latest BioSig Technologies, Inc. (BSGM) stock quote, history, news and other vital information to help you with your stock trading and investing.Mar 7, 2023 · Durect (DRRX) came out with a quarterly loss of $0.46 per share versus the Zacks Consensus Estimate of a loss of $0.53. This compares to loss of $0.30 per share a year ago. These figures are ... Durect (DRRX) delivered earnings and revenue surprises of -4% and 41.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?A share price of Durect Corp [DRRX] is currently trading at $2.92, up 12.31%. An important factor to consider is whether the stock is rising or falling in short-term value. The DRRX shares have gain 13.62% over the last week, with a monthly amount glided 3.55%, and seem to be holding up well over aDurect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...Find the latest Galera Therapeutics, Inc. (GRTX) stock quote, history, news and other vital information to help you with your stock trading and investing.Get the latest Checkpoint Therapeutics Inc (CKPT) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.DRRX Stock Performance on November 8, 2023: On November 8, 2023, DRRX stock had a volatile day of trading. The stock opened at $0.83 and traded in a range of $0.58 to $0.83 throughout the day. The trading volume was 693,861 shares. DRRX is a pharmaceutical company based in Cupertino, California, with a market capitalization of $75.3 million.DURECT Co. (NASDAQ:DRRX – Free Report) – Northland Capmk boosted their FY2023 EPS estimates for shares of DURECT in a report issued on Tuesday, November 14th. Northland Capmk analyst C. Byrnes now anticipates that the specialty pharmaceutical company will post earnings per share of ($1.47) for the year, up from …Last reporting date. November 22, 2023. EPS forecast (this quarter) -$0.86. Annual revenue (last year) $0.00. Annual profit (last year) -$14.6M. Net profit margin.The 4 analysts offering 1 year price forecasts for DRRX have a max estimate of — and a min estimate of —. Analyst rating Based on 4 analysts giving stock ratings to DRRX in the past 3 months. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...View live DURECT Corporation chart to track its stock's price action. Find market predictions, DRRX financials and market news. Search. Products; Community; ... Market closed Market closed. No trades. See on Supercharts. Overview . News Ideas Financials Technicals Forecast . DRRX chart. Today −2.29% 5 days 1.31% 1 month −74.80% 6 …The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year.3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ...Future criteria checks 2/6. DURECT is forecast to grow earnings and revenue by 16.9% and 47.9% per annum respectively while EPS is expected to grow by 19.9% per annum.Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ...You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.Buying a stock under $10 means that for that same $100 you can pick up 10 shares instead of just one. Generally, stocks under $10 to buy are more likely to be growth stocks with longer runways to ...Cascades deeply regrets and is saddened to announce the death of one of its cofounders, Mr. Bernard Lemaire, at the age of 87. Find the latest Cascades Inc. (CAS.TO) stock quote, history, news and other vital information to help you with your stock trading and investing.Wall Street Analysts Think Durect (DRRX) Could Surge 594.98%: Read This Before Placing a Bet Zacks - Thu May 11, 8:55AM CDT . The mean of analysts' price targets for Durect (DRRX) points to a 595% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in... Find the latest Durect Corporation (DRRX) stock forecast, 12-month price target, predictions and analyst recommendations.Durect (NASDAQ: DRRX) is one of my favorite cheap stocks to buy right now. It’s current price looks even more tempting given the company completed a 1-to-10 stock split late last year. Durect is ...About CohBar Stock (NASDAQ:CWBR) CohBar, Inc., a clinical stage biotechnology company, develops mitochondria and peptides based therapeutics for the treatment of chronic and age-related diseases. It develops CB4211, a therapeutic that is in Phase 1a/1b clinical trial for the treatment of nonalcoholic steatohepatitis and obesity; …See historical performance and comparison. View Valuation. Research DURECT's (Nasdaq:DRRX) stock price, latest news & stock analysis. Find everything …Stock Price and Dividend Data for Durect Corp (DRRX), including dividend dates, dividend yield, company news, and key financial metrics.The BigBear.ai Holdings stock price gained 1.72% on the last trading day (Wednesday, 22nd Nov 2023), rising from $1.74 to $1.77. During the last trading day the stock fluctuated 6.32% from a day low at $1.74 to a day high of $1.85. The price has risen in 8 of the last 10 days and is up by 18.79% over the past 2 weeks.Financial Health criteria checks 5/6. DURECT has a total shareholder equity of $14.4M and total debt of $18.7M, which brings its debt-to-equity ratio to 129.8%. Its total assets and total liabilities are $54.7M and $40.3M respectively. 3 analysts have issued 12-month price objectives for Broadwind's stock. Their BWEN share price targets range from $6.00 to $9.00. On average, they predict the company's share price to reach $7.67 in the next twelve months. This suggests a possible upside of 250.1% from the stock's current price. View analysts price targets for BWEN or view top ...Latest Let’s talk about penny stocks. These are equities that trade for less than $5 per share, at the very bottom of the price range. While they are pricedUpside potential of 134% is at play.Overall, the bulls take the lead on this one. Out of 5 total reviews published in the last three months, all 5 analysts rated the stock a Buy. Therefore, the ...Nov 27, 2023 · A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. DURECT Stock Earnings. The value each DRRX share was expected to gain vs. the value that each DRRX share actually gained. DURECT ( DRRX) reported Q3 2023 earnings per share (EPS) of -$0.11, beating estimates of -$0.41 by 72.98%. In the same quarter last year, DURECT 's earnings per share (EPS) was -$0.11. DURECT is expected to release next ... Great weather can motivate you to get out of the house, while inclement weather can make you feel lethargic. When the weather’s great we want to be outside enjoying it. For the best regional weather forecasts check out AccuWeather.Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears.Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.Drrx stock forecast

In the world of business, cash flow is king. Having a clear understanding of your company’s cash flow is essential for making informed financial decisions and ensuring the long-term success of your business.. Drrx stock forecast

drrx stock forecast

Find the latest Earnings Report Date for DURECT Corporation Common Stock (DRRX) at Nasdaq.com.Let’s speak about penny stocks. These are equities that commerce for lower than $5 per share, on the very backside of the value vary. Whereas they’re priced that low for a purpose – and the explanations might fluctuate – a low value in itself doesn’t imply that the inventory’s fundamentals are bitter. Sensible buyers can …According to . 2 Wall Street analysts that have issued a 1 year DRRX price target, the average DRRX price target is $34.00, with the highest DRRX stock price forecast at $41.00 and the lowest DRRX stock price forecast at $27.00.Investing in the stock market takes a lot of courage, a lot of research, and a lot of wisdom. One of the most important steps is understanding how a stock has performed in the past. Of course, the past is not a guarantee of future performan...For DURECT stock forecast for 2026, 12 predictions are offered for each month of 2026 with average DURECT stock forecast of $0.87, a high forecast of $1.25, and a low forecast of $0.48. The average DURECT stock forecast 2026 represents a 39.89% increase from the last price of $0.620000004768372. Nasdaq provides market information on after hours trading daily from 4:15 p.m. ET to 3:30 p.m. ET on the following day. $233.0401 -1.2599 -0.54%. $190.76 +1.07. DURECT Corporation Common Stock ...GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.DURECT Corporation (Nasdaq: DRRX) ("DURECT"), a biopharmaceutical company focused on developing its epigenetic regulator program for the treatment of acute organ injury and chronic liver diseases ...Oct 2, 2023 · Nevertheless, analysts rate DRRX a unanimous strong buy with a $29.80 target, implying 1,097% upside. On the date of publication, ... PayPal Stock Is a No-Gainer, Not a No-Brainer The stock’s $2.58 trading price and $29.80 average price target reflects the high potential of the leading drug candidate – and implies a gain of 1,064% in the coming year. (See DRRX stock ...Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Get the latest Oncology Pharma Inc (ONPH) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.Based on short-term price targets offered by two analysts, the average price target for Durect comes to $6.75. The forecasts range from a low of $5.00 to a high of $8.50. The average price target ...Welcome to Seeking Alpha's Catalyst Watch - a breakdown of some of next week's actionable events that stand out. Read more about the events that may impact stock prices next week.Celebrations may be in order for DURECT Corporation ( NASDAQ:DRRX ) shareholders, with the analysts delivering a...Dec 1, 2023 · DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops larsucosterol (DUR-928), an ... May 26, 2020 · DRRX stock forecast Our latest prediction for Durect Corp's stock price was made on the May 26, 2020 when the stock price was at 2.66$. In the short term (2weeks), DRRX's stock price should outperform the market by 4.58%. During that period the price should oscillate between -11.17% and +17.56%. Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... If you’re looking for stocks under $10 to buy, you can do a lot worse than these highly-rated picks. BBAI BigBear.ai $4.05 APPH AppHarvest $0.95 DRRX Durect 5.18 AUVI Applied UV $1.13 ARDX ...Nov 13, 2023 · Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade. Real time Durect (DRRX) stock price quote, stock graph, news & analysis.Nov 6, 2023 · The Price and Consensus chart displays the company's stock price along with the consensus estimate. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The ... DRRX Stock Price Forecast. The average stock forecast for DURECT Corp (DRRX) in the next 12 months is 30.40 USD. This price target corresponds to an upside of 10.83%. The range of stock forecasts for DRRX is 12.12 - 43.05 USD. …Durect (DRRX) shares soared 11.8% in the last trading session to close at $6.65. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to ...Get the latest Marker Therapeutics Inc (MRKR) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.DRRX's stock price has decreased by -84.09% in the past year and price targets may not have had time to catch up. Stock Price Forecast According to 2 stock analysts, the average 12-month stock price forecast for DURECT stock is $36.5, which predicts an increase of 5,499.88%.Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...Analyst Price Forecast Suggests 670.31% Upside. As of April 24, 2023, the average one-year price target for Durect is 36.98. The forecasts range from a low of 32.32 to a high of $46.20. The ...Jul 20, 2023 · /PRNewswire/ -- DURECT Corporation (Nasdaq: DRRX) ... The shares of common stock and accompanying warrants are being sold at a combined purchase price of $5.015 per share and accompanying warrant. Get the latest DURECT Corporation (DRRX) stock news and headlines to help you in your trading and investing decisions.Durect (NASDAQ: DRRX) stock is falling hard on Wednesday after the late-stage biopharmaceutical company released results from a Phase 2b clinical trial. This clinical trial covered the efficiency ...On March 14, 2023, JonesTrading initiated coverage of DURECT with a Buy recommendation. Analyst Price Forecast Suggests 660.43% Upside. As of March 14, 2023, the average one-year price target for ...Celebrations may be in order for DURECT Corporation ( NASDAQ:DRRX ) shareholders, with the analysts delivering a...Find the latest DURECT Corporation (DRRX) stock quote, history, news and other vital information to help you with your stock trading and investing. On March 14, 2023, JonesTrading initiated coverage of DURECT with a Buy recommendation. Analyst Price Forecast Suggests 660.43% Upside. As of March 14, 2023, the average one-year price target for ...Nov 13, 2023 · Nevertheless, the stock market reaction to the news is punishing, with a ~80% drop in the stock price (from $2.58 to $0.53), which was quickly followed by HC Wainwright's downgrade. A high-level overview of DURECT Corporation (DRRX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Durect Stock Prediction. AVB. 40... DURECT · Dutch Bros · D-Wave Quantum · DXC Technology Company · DXP Enterprises · Dyadic International · Dycom Industries · Dynagas LNG Partners LP · Dynatrace.Nowadays finding high-quality stock photos for personal or commercial use is very simple. You just need to search the photo using a few descriptive words and let Google do the rest of the work.Find the latest DURECT Corporation (DRRX) stock analysis from Seeking Alpha’s top analysts: exclusive research and insights from bulls and bears. ... Latest Stock Analysis. Follow $0.66 0.01 (+1 ...Durect (DRRX) In a report released today, Kristen Kluska from Cantor Fitzgerald reiterated a Buy rating on Durect, with a price target of $44.00 . The company’s shares closed last Wednesday at ...Stock Price Forecast. The 1 analysts offering 12-month price forecasts for First Wave BioPharma Inc have a median target of 11.00, with a high estimate of 11.00 and a low estimate of 11.00. The ...DURECT Corporation Common Stock (DRRX) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets. Dec 1, 2023 · It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ... It's typically categorized as a valuation metric and is most often quoted as Cash Flow per Share and as a Price to Cash flow ratio. In this case, it's the cash flow growth that's being looked at ...DRRX Forecast — Price Target — Prediction for 2024 USD / / / Forecast DURECT Corporation DRRXNASDAQ DRRXNASDAQ 0.6518USD +0.0318 +5.13% At close at Dec 1, 16:49 UTC-8 See on Supercharts Overview …Nov 8, 2023 · Durect Corp (DRRX) $0.66 0.01 (1.54%) 13:00 EST DRRX Stock Quote Delayed 30 Minutes. DURECT Corp ( DRRX) is up 3.29% today. DRRX has an Overall Score of 75. Find out what this means to you and get the rest of the rankings on DRRX! DRRX stock closed at $7.00 and is up $0.23 during pre-market trading. Pre-market tends to be more volatile due to significantly lower volume as most investors only trade between standard trading hours.GEVO Stock 12 Months Forecast. $6.47. (528.16% Upside) Based on 3 Wall Street analysts offering 12 month price targets for Gevo in the last 3 months. The average price target is $6.47 with a high forecast of $14.00 and a low forecast of $2.00. The average price target represents a 528.16% change from the last price of $1.03.. Can i buy a house with 600 credit score